Building reliable organoid models for human-relevant drug discovery
In this Drug Target Review article, Aaron Risinger of Molecular Devices explores how organoid technology is transforming drug discovery with human-relevant, 3D models that better reflect tissue complexity and patient variability. He highlights how automation, AI, and patient-derived systems are driving more predictive research—and why standardization will be key to realizing their full potential.